Titan Pharmaceuticals Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Titan Pharmaceuticals Inc |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Titan Pharma Q1 2025 10-Q filed. Financials updated.
AI Summary
Titan Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position. Specific financial figures for the quarter and comparative periods are presented, including details on preferred stock, common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with an update on Titan Pharmaceuticals' financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Titan Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Period End Date (Latest reported quarter)
- 2024-12-31 — Prior Year End Date (Comparative balance sheet data)
- 2024-03-31 — Prior Year Quarter End Date (Comparative balance sheet data)
Key Players & Entities
- TITAN PHARMACEUTICALS INC (company) — Filer
- 0000910267 (company) — Central Index Key
- 20250331 (date) — Period of Report
- 20250514 (date) — Filing Date
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is Titan Pharmaceuticals Inc.'s Central Index Key (CIK)?
Titan Pharmaceuticals Inc.'s CIK is 0000910267.
What are the main financial statement components detailed in the filing for the period ending March 31, 2025?
The filing details preferred stock, common stock, additional paid-in capital, and retained earnings for the period.
What is the company's fiscal year end?
Titan Pharmaceuticals Inc.'s fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding TITAN PHARMACEUTICALS INC.